| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | thalidomide | CTRPv2 | pan-cancer | AAC | 0.026 | 0.6 |
| mRNA | PI-103 | CTRPv2 | pan-cancer | AAC | -0.016 | 0.6 |
| mRNA | Nutlin-3 | CTRPv2 | pan-cancer | AAC | -0.016 | 0.6 |
| mRNA | cabozantinib | CTRPv2 | pan-cancer | AAC | -0.017 | 0.6 |
| mRNA | KU-0063794 | CTRPv2 | pan-cancer | AAC | -0.016 | 0.6 |
| mRNA | CAY10576 | CTRPv2 | pan-cancer | AAC | -0.018 | 0.6 |
| mRNA | importazole | CTRPv2 | pan-cancer | AAC | -0.017 | 0.6 |
| mRNA | PD318088 | CTRPv2 | pan-cancer | AAC | -0.016 | 0.6 |
| mRNA | selumetinib:JQ-1 (4:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.015 | 0.7 |
| mRNA | tacedinaline | CTRPv2 | pan-cancer | AAC | -0.018 | 0.7 |